[Use of lithium carbonate in a psychiatric institution].
D001291:Attitude of Health Personnel; D002254:Carbonates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004357:Drug Synergism; D006801:Humans; D008607:Intellectual Disability / Q000188:drug therapy; D008094:Lithium / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001523:Mental Disorders / Q000188:drug therapy*; D009404:Nephrotic Syndrome; D009497:Neurotic Disorders / Q000188:drug therapy; D010817:Physician-Patient Relations; D011618:Psychotic Disorders / Q000188:drug therapy; D006435:Renal Dialysis; D012959:Socioeconomic Factors; D014149:Tranquilizing Agents / Q000627:therapeutic use
D002254:Carbonates; D014149:Tranquilizing Agents; D008094:Lithium
L'utilisation du carbonate de lithium dans une institution psychiatrique.